Literature DB >> 23243487

Synthesis and SAR of 1-hydroxy-1H-benzo[d]imidazol-2(3H)-ones as Inhibitors of D-Amino Acid Oxidase.

James F Berry1, Dana V Ferraris, Bridget Duvall, Niyada Hin, Rana Rais, Jesse Alt, Ajit G Thomas, Camilo Rojas, Kenji Hashimoto, Barbara S Slusher, Takashi Tsukamoto.   

Abstract

A series of 1-hydroxy-1H-benzo[d]imidazol-2(3H)-ones were synthesized and evaluated for their ability to inhibit human and porcine forms of D-amino acid oxidase (DAAO). Inhibitory potency is largely dependent on the size and position of substituents on the benzene ring with IC(50) values of the compounds ranging from 70 nM to greater than 100 µM. Structure-activity relationships of this new class of DAAO inhibitors will be presented in detail along with comparisons to previously published SAR data from other classes of DAAO inhibitors. Some of these compounds were given to mice orally together with D-serine to assess their effects on plasma D-serine pharmacokinetics.

Entities:  

Year:  2012        PMID: 23243487      PMCID: PMC3519437          DOI: 10.1021/ml300212a

Source DB:  PubMed          Journal:  ACS Med Chem Lett        ISSN: 1948-5875            Impact factor:   4.345


  15 in total

Review 1.  From revolution to evolution: the glutamate hypothesis of schizophrenia and its implication for treatment.

Authors:  Bita Moghaddam; Daniel Javitt
Journal:  Neuropsychopharmacology       Date:  2011-09-28       Impact factor: 7.853

2.  D-amino-acid oxidase is involved in D-serine-induced nephrotoxicity.

Authors:  Masao Maekawa; Tadashi Okamura; Noriyuki Kasai; Yuuichi Hori; Karl H Summer; Ryuichi Konno
Journal:  Chem Res Toxicol       Date:  2005-11       Impact factor: 3.739

Review 3.  Recent advances in the discovery of D-amino acid oxidase inhibitors and their therapeutic utility in schizophrenia.

Authors:  Dana V Ferraris; Takashi Tsukamoto
Journal:  Curr Pharm Des       Date:  2011       Impact factor: 3.116

4.  Structural basis of D-DOPA oxidation by D-amino acid oxidase: alternative pathway for dopamine biosynthesis.

Authors:  Tomoya Kawazoe; Hideaki Tsuge; Takahito Imagawa; Kenji Aki; Seiki Kuramitsu; Kiyoshi Fukui
Journal:  Biochem Biophys Res Commun       Date:  2007-02-08       Impact factor: 3.575

5.  The discovery of fused pyrrole carboxylic acids as novel, potent D-amino acid oxidase (DAO) inhibitors.

Authors:  Tim Sparey; Pravien Abeywickrema; Sarah Almond; Nick Brandon; Noel Byrne; Alister Campbell; Pete H Hutson; Marlene Jacobson; Brian Jones; Sanjeev Munshi; Danette Pascarella; Andrew Pike; G Sridhar Prasad; Nancy Sachs; Melanie Sakatis; Vinod Sardana; Shankar Venkatraman; Mary Beth Young
Journal:  Bioorg Med Chem Lett       Date:  2008-04-13       Impact factor: 2.823

6.  Co-administration of a D-amino acid oxidase inhibitor potentiates the efficacy of D-serine in attenuating prepulse inhibition deficits after administration of dizocilpine.

Authors:  Kenji Hashimoto; Yuko Fujita; Mao Horio; Shinsui Kunitachi; Masaomi Iyo; Dana Ferraris; Takashi Tsukamoto
Journal:  Biol Psychiatry       Date:  2009-02-12       Impact factor: 13.382

7.  The behavioral and neurochemical effects of a novel D-amino acid oxidase inhibitor compound 8 [4H-thieno [3,2-b]pyrrole-5-carboxylic acid] and D-serine.

Authors:  Sean M Smith; Jason M Uslaner; Lihang Yao; Chadwick M Mullins; Nathan O Surles; Sarah L Huszar; Caitlyn H McNaughton; Danette M Pascarella; Monika Kandebo; Richard M Hinchliffe; Tim Sparey; Nicholas J Brandon; Brian Jones; Shankar Venkatraman; Mary Beth Young; Nancy Sachs; Marlene A Jacobson; Peter H Hutson
Journal:  J Pharmacol Exp Ther       Date:  2008-12-16       Impact factor: 4.030

8.  Pharmacokinetics of oral D-serine in D-amino acid oxidase knockout mice.

Authors:  Rana Rais; Ajit G Thomas; Krystyna Wozniak; Ying Wu; Hanna Jaaro-Peled; Akira Sawa; Christine A Strick; Sandra J Engle; Nicholas J Brandon; Camilo Rojas; Barbara S Slusher; Takashi Tsukamoto
Journal:  Drug Metab Dispos       Date:  2012-07-26       Impact factor: 3.922

9.  Discovery, SAR, and pharmacokinetics of a novel 3-hydroxyquinolin-2(1H)-one series of potent D-amino acid oxidase (DAAO) inhibitors.

Authors:  Allen J Duplantier; Stacey L Becker; Michael J Bohanon; Kris A Borzilleri; Boris A Chrunyk; James T Downs; Lain-Yen Hu; Ayman El-Kattan; Larry C James; Shenping Liu; Jiemin Lu; Noha Maklad; Mahmoud N Mansour; Scot Mente; Mary A Piotrowski; Subas M Sakya; Susan Sheehan; Stefanus J Steyn; Christine A Strick; Victoria A Williams; Lei Zhang
Journal:  J Med Chem       Date:  2009-06-11       Impact factor: 7.446

10.  In vitro and in vivo pharmacological profile of AS057278, a selective d-amino acid oxidase inhibitor with potential anti-psychotic properties.

Authors:  Tiziana Adage; Anne-Cécile Trillat; Anna Quattropani; Dominique Perrin; Laurent Cavarec; Jeffrey Shaw; Oxana Guerassimenko; Claudio Giachetti; Béatrice Gréco; Ilya Chumakov; Serge Halazy; Arthur Roach; Paola Zaratin
Journal:  Eur Neuropsychopharmacol       Date:  2007-08-02       Impact factor: 4.600

View more
  8 in total

1.  Structure-Metabolism Relationships in the Glucuronidation of d-Amino Acid Oxidase Inhibitors.

Authors:  Sarah C Zimmermann; Rana Rais; Jesse Alt; Caitlin Burzynski; Barbara S Slusher; Takashi Tsukamoto
Journal:  ACS Med Chem Lett       Date:  2014-10-21       Impact factor: 4.345

Review 2.  Bioactive heterocycles containing endocyclic N-hydroxy groups.

Authors:  Reshma Rani; Carlotta Granchi
Journal:  Eur J Med Chem       Date:  2014-11-18       Impact factor: 6.514

3.  Synthesis of kojic acid derivatives as secondary binding site probes of D-amino acid oxidase.

Authors:  Mithun Raje; Niyada Hin; Bridget Duvall; Dana V Ferraris; James F Berry; Ajit G Thomas; Jesse Alt; Camilo Rojas; Barbara S Slusher; Takashi Tsukamoto
Journal:  Bioorg Med Chem Lett       Date:  2013-05-01       Impact factor: 2.823

4.  Validation of tautomeric and protomeric binding modes by free energy calculations. A case study for the structure based optimization of D-amino acid oxidase inhibitors.

Authors:  Zoltán Orgován; György G Ferenczy; Thomas Steinbrecher; Bence Szilágyi; Dávid Bajusz; György M Keserű
Journal:  J Comput Aided Mol Des       Date:  2018-01-15       Impact factor: 3.686

5.  Molecular modeling studies of 1,2,4-triazine derivatives as novel h-DAAO inhibitors by 3D-QSAR, docking and dynamics simulations.

Authors:  Ping Ping Qian; Shuai Wang; Kai Rui Feng; Yu Jie Ren
Journal:  RSC Adv       Date:  2018-04-17       Impact factor: 4.036

6.  Synthesis of 1-isopropyl-3-acyl-5-methyl-benzimidazolone derivatives and their antimicrobial activity.

Authors:  Nan Xu; Chunnan Yang; Xinqi Gan; Shaopeng Wei; Zhiqin Ji
Journal:  Int J Mol Sci       Date:  2013-03-26       Impact factor: 5.923

7.  Novel human D-amino acid oxidase inhibitors stabilize an active-site lid-open conformation.

Authors:  Ryan T Terry-Lorenzo; Lawrence E Chun; Scott P Brown; Michele L R Heffernan; Q Kevin Fang; Michael A Orsini; Loredano Pollegioni; Larry W Hardy; Kerry L Spear; Thomas H Large
Journal:  Biosci Rep       Date:  2014-08-11       Impact factor: 3.840

8.  6-Hydroxy-1,2,4-triazine-3,5(2H,4H)-dione Derivatives as Novel D-Amino Acid Oxidase Inhibitors.

Authors:  Niyada Hin; Bridget Duvall; Dana Ferraris; Jesse Alt; Ajit G Thomas; Rana Rais; Camilo Rojas; Ying Wu; Krystyna M Wozniak; Barbara S Slusher; Takashi Tsukamoto
Journal:  J Med Chem       Date:  2015-09-03       Impact factor: 7.446

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.